Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02486341
NA

Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

Basal insulin is widely used in older patients with diabetes. Human insulin Neutral Protamine Hagedorn (NPH) has been proposed as basal insulin in older (75 years or older) frail and dependent patients due to its shorter action. However, no study has analysed the glycaemic profile in elderly subjects according to the basal insulin used, particularly in frail or disabled patients. The aim of this study is to measure intra-day glycaemic variability according basal insulin (human NPH or long acting analogues) in older (75 and older) frail or disabled patients with diabetes using continuous glucose monitoring system.

Key Details

Gender

All

Age Range

75 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2016-03-31

Completion Date

2019-01-28

Last Updated

2026-05-22

Healthy Volunteers

No

Conditions

Interventions

DRUG

Insulin

Continuous glucose monitoring system over 120-hour period.

Locations (1)

University Hospital of Bordeaux - Xavier Arnozan Hospital

Pessac, France